VVOS Vivos Therapeutics, Inc.
$0.18▲ +1.32%
Healthcare
Other
After hours
$0.18▼ -4.29%
Sep 11, 7:56 PM ET
Volume 1.44M
Avg Volume (10D) 62.71M
Key Metrics & Fundamentals
Market Cap
$3.70M
P/E Ratio
–
Div Yield
–%
52W Range
0.16 - 3.70
% vs 50 MA
-44.96%
% vs 200 MA
-83.11%
RSI-14
31.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$3.56M
Gross Rev
$5.15M
Gross Profit
$2.95M
EBITDA
-$4.31M
COGS
$2.20M
Operating Exp
$7.78M
Operating Income
-$4.83M
EBIT
-$4.83M
Pretax Income
-$5.52M
Net Income
-$5.48M
EPS (Diluted)
-0.31
Price & Volume History
Loading chart…
Recent News
Vivos Therapeutics Announces Material Debt Reduction
GlobeNewswire · Sep 8, 2026 12:45 PM
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
TMX Newsfile · Sep 1, 2026 12:00 PM
BC-Most Active Stocks
Associated Press · Aug 31, 2026 2:30 PM
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
GlobeNewswire · Aug 28, 2026 12:45 PM
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
GlobeNewswire · Aug 25, 2026 12:45 PM
Sector Update: Healthcare Stocks Fall Late Afternoon
MT Newswires · Aug 20, 2026 7:47 PM
Vivos Therapeutics Opens Nevada Sleep Treatment Center
MT Newswires · Aug 20, 2026 3:13 PM
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
GlobeNewswire · Aug 20, 2026 2:24 PM
Vivos Therapeutics Inc (VVOS) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% on ...
GuruFocus.com · Aug 18, 2026 9:01 PM
Vivos Therapeutics shares slide after Q2 revenue falls short of forecasts
InvestorsHub · Aug 17, 2026 11:05 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See VVOS's money flow as a full page
Social Sentiment
No Reddit posts found for VVOS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.